DIPHTHERIA VACCINE MARKET ANALYSIS

Diphtheria Vaccine Market, by Vaccine Type (DTaP vaccine, DT vaccine, Tdap vaccine, and Td vaccine), by Age Group (Pediatrics and Adults), by End User (Hospitals, Clinics, and Vaccination Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jan 2023
Code : CMI5480
Pages :190
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Restraints & Challenges:

High cost of diphtheria vaccines
Inadequate access to vaccines in under developed countries

Global Diphtheria Vaccine Market: Restraint

The side effects of Diphtheria vaccine

The major factors that can hamper growth of the global diphtheria vaccine market over the forecast period include high cost of the diphtheria vaccines and inadequate access to vaccines in under developed countries. For instance, according to centers for disease control and prevention (CDC) in November 2022, the cost of Quadracel, a diphtheria vaccine manufactured by Sanofi Pasteur, a vaccines division of the French multinational pharmaceutical company Sanofi, is US$ 58.35 for a single vial. Key market player should focus on developing cost effective vaccine.